APA

Kelley J. A., Litterst C. L., Roth J. S., Vistica D. T., Poplack D. G., Cooney D. A., Nadkarni M., Balis F. M., Broder S. & Johns D. G. (19880210). The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Kelley J A, Litterst C L, Roth J S, Vistica D T, Poplack D G, Cooney D A, Nadkarni M, Balis F M, Broder S and Johns D G. 19880210. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Kelley J. A., Litterst C. L., Roth J. S., Vistica D. T., Poplack D. G., Cooney D. A., Nadkarni M., Balis F. M., Broder S. and Johns D. G. (19880210). The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Kelley J A, Litterst C L, Roth J S, Vistica D T, Poplack D G, Cooney D A, Nadkarni M, Balis F M, Broder S and Johns D G. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. : Drug metabolism and disposition: the biological fate of chemicals. 19880210.